Cargando…
Incretin-based therapies in 2021 – Current status and perspectives for the future
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Published by Elsevier Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8321622/ https://www.ncbi.nlm.nih.gov/pubmed/34333000 http://dx.doi.org/10.1016/j.metabol.2021.154843 |
| _version_ | 1783730888954085376 |
|---|---|
| author | Rizzo, Manfredi Nauck, Michael A. Mantzoros, Christos S. |
| author_facet | Rizzo, Manfredi Nauck, Michael A. Mantzoros, Christos S. |
| author_sort | Rizzo, Manfredi |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8321622 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Published by Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-83216222021-07-30 Incretin-based therapies in 2021 – Current status and perspectives for the future Rizzo, Manfredi Nauck, Michael A. Mantzoros, Christos S. Metabolism Articles from the Incretin Hormones and Incretin-based Glucose-lowering Medications Special Issue, Edited by Michael Nauck, Manfredi Rizzo and Christos Mantzoros Published by Elsevier Inc. 2021-09 2021-07-30 /pmc/articles/PMC8321622/ /pubmed/34333000 http://dx.doi.org/10.1016/j.metabol.2021.154843 Text en © 2021 Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Articles from the Incretin Hormones and Incretin-based Glucose-lowering Medications Special Issue, Edited by Michael Nauck, Manfredi Rizzo and Christos Mantzoros Rizzo, Manfredi Nauck, Michael A. Mantzoros, Christos S. Incretin-based therapies in 2021 – Current status and perspectives for the future |
| title | Incretin-based therapies in 2021 – Current status and perspectives for the future |
| title_full | Incretin-based therapies in 2021 – Current status and perspectives for the future |
| title_fullStr | Incretin-based therapies in 2021 – Current status and perspectives for the future |
| title_full_unstemmed | Incretin-based therapies in 2021 – Current status and perspectives for the future |
| title_short | Incretin-based therapies in 2021 – Current status and perspectives for the future |
| title_sort | incretin-based therapies in 2021 – current status and perspectives for the future |
| topic | Articles from the Incretin Hormones and Incretin-based Glucose-lowering Medications Special Issue, Edited by Michael Nauck, Manfredi Rizzo and Christos Mantzoros |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8321622/ https://www.ncbi.nlm.nih.gov/pubmed/34333000 http://dx.doi.org/10.1016/j.metabol.2021.154843 |
| work_keys_str_mv | AT rizzomanfredi incretinbasedtherapiesin2021currentstatusandperspectivesforthefuture AT nauckmichaela incretinbasedtherapiesin2021currentstatusandperspectivesforthefuture AT mantzoroschristoss incretinbasedtherapiesin2021currentstatusandperspectivesforthefuture |